Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
There is a direct association between cancer and thrombosis (blood clots). The purpose of this study is to determine the best dose of an antithrombotic (prevents blood clots) agent called fondaparinux in non-small cell lung cancer(NSCLC). Patients will also receive chemotherapy.
Epistemonikos ID: be2b556742836c10b1c51ea2160f088d9d5dd287
First added on: May 04, 2024